Nandro 300 Nandrolone Blend Human Labs
After oral administration trimetazidnn durabolin rapidly and almost completely absorbed in the gastrointestinal tract. Bioavailability – 90%. The time to reach maximum plasma concentration – 2 chasa (maximum concentration after a single dose of 20 mg of trimetazidine about 55 ng / ml). Easily penetrates the blood-tissue barriers. Poluvyvёdeniya period . Contact with blood plasma proteins – 16%. Report from the body by the kidneys (60% unchanged).
Indications for use Ischemic heart disease: prevention of angina attacks durabolin (in the complex therapy).
Kohleovestibulyarny violations ischemic nature, such as dizziness, tinnitus, hearing loss. Chorioretinal vascular disorders.
Pregnancy and lactation The drug is contraindicated in pregnancy because durabolin of the lack of clinical data on the safety of its use. If necessary, the appointment during lactation should stop breastfeeding. It is not known whether trimetazidine is excreted in breast milk. In experimental studies found no teratogenic effects of trimetazidine.
Dosing and Administration Inside, during a meal. The recommended dosing regimen – 2-3 capsules (40-60 mg) per day, 2-3 hours. The course of treatment – on doctor’s advice.
Side effects: Allergic reactions (itchy skin), seldom durabolin – dyspeptic symptoms (nausea, vomiting, gastralgia). Rarely – headache, a feeling of palpitations.
Overdosing Currently, the cases of overdose have been reported.
Interaction with other medicinal products are not described.
Cautions Do not use for the relief of angina attacks. Do not indicated for the initial course of therapy of unstable angina or myocardial infarction. In the case of angina attack should review and adapt the treatment.
Effect on management of vehicles and mechanisms Trimetazidine does not affect the ability to drive and transport works and require high speed of psychomotor reactions.
Following oral administration trimebutine is rapidly absorbed from the gastrointestinal tract, maximum plasma concentration decanoate is achieved in 1-2 hours. The bioavailability is 4-6%. The volume of distribution (Vd) – 88 l. The degree of binding to plasma proteins is low – about 5%. Trimebutin slightly crosses the placental barrier.
Metabolism and excretion of trimebutine biotransformed in the liver and excreted in the urine primarily as metabolites (approximately 70% during the first 24 hours).
Use in children: diarrheal disorders associated with impaired gastrointestinal motility fact.
Contraindications : Hypersensitivity to the decanoate components included in the composition of the drug. Children under 3 years – for this dosage form.
Application of pregnancy and lactation is not recommended to use the drug in the I trimester of pregnancy. Do not appoint Trimedat lactation, due to the lack of reliable clinical data supporting the safety of the drug during this period. In experimental studies revealed no data on the teratogenicity and embryotoxicity drug.
Dosing and Administration Inside. Adults and children from 12 years.: 100-200 mg 3 times a day Children 3-5 years: 25 mg 3 times daily. Chi
Watch video "nANDROLONE"Nandro 300 Nandrolone Blend Human Labs
Deca, Duraxyl, Nandroxyl, Nandrolona, Deca-Durabolin, Durabol, Durabolin, NPP, Nandrodex, Decaplex, Decatrex, Decos, Durobolic, Decabol, Decabolic, Decaver, Nandrobolin, Newdec, Pylodec, Axidrol, Therabol, Zebol, Myobolin, Nandronit D, Cheribol, Growdeca, Gemdec, Nitrobol, Synobol, Grodec, Deca-Duralin, NandroloneDrug Description
Transparent oily solution of light yellow or yellow color, containing a characteristic odor.Deca 300 Composition
1 mL of solution contains: Active substance: Nandrolone Decanoate 300 mgBodybuilding Benefits
Injectable anabolic steroid with longer anabolic activity and lower androgenic effect. It has the capacity to increase protein synthesis in muscle cells and help to achieve a positive nitrogen balance. The drug is used for muscle growth, appetite stimulation, increased red blood cell production and bone density.Therapeutic Indication
Is used in tduring renal anemia (hemoglobin and cell mass increase), diabetic retinopathy, miodistrofia, Werding-Hoffmann spinal amyotrophy breast cancer (adjuvant), glomerulonephritis, extensive burns, osteoporosis and it can also act as a progestin-based contraceptive.Dosage (Men)
200-600 mg per weekDosage (Women)Active LifeDeca 300 Side Effects
High blood pressure and a prolonged time for blood clotting, nasal bleeding, as well as increased production of the sebaceous gland and acne, headaches and sexual overstimulation in men. androgenic side effects as masculinization of voice (often inconvertible), hirsutism, acne, high libido and, at times, hypertrophy of clitoris in women.Deca 300 Contraindications/Precautionary Measures
Not recommended in case of hypersensitivity to the drug, ephrotic syndrome, acute and chronic liver disease, including alcoholic nephritis, prostate cancer, male breast cancer, breast carcinoma in women with hypercalcemia, severe atherosclerosis, n pregnancy, lactation. It is recommended to monitor the virilization effects level, as well the levels of lipidemia and cholesterol.Overdosage
There are no registered cases of overdosage.Deca 300 Stack/Cycle
The length of cycle is about 8-10 weeks and it is taken in combination with Strombafort, Parabolan and Oxandrolone to gain muscle mass and to avoid water retention, with antiestrogen medications like Proviroxyl, Anastrozol or Nolvaxyl.Package Presentation
10 ml vial (300 mg/ml)Storage
To be store in a dry place, protected from light, at a temperature of 15-25 ° C. Keep out of reach of children.Deca 300 Referrers
Deca 300 Dragon Pharma
Dragon Pharma Injectable Steroids
U.S. Brand Names: Deca-Durabolin
Pharmacologic Category: Androgen
General Information Nandrolone decanoate is a parenteral anabolic steroid. It is primarily used to treat anemia, chronic renal failure, osteoporosis and AIDS-associated wasting syndrome. This agent is known to increase hemoglobin and red cell mass. With the development of recombinant human erythropoietin, nandrolone decanoate use in anemia associated with chronic renal failure has declined. It has also been the subject of drug misuse and abuse, often producing adverse effects such as changes in libido, hepatotoxicity, increased risk of cardiovascular disease, and antisocial behavior. Some of the masculinizing effects in women can be irreversible. Nandrolone decanoate was approved by the FDA in 1983 and became a controlled substance in 1991.
Mechanism of Action Nandrolone decanoate shares the actions of endogenous androgens such as testosterone. Exogenous androgens such as nandrolone decanoate promote protein anabolism and stimulate appetite which results in a reversal of catabolic processes and negative nitrogen balance. Increases in lean body mass in patients with cachexia (e.g., malnourished dialysis patients) and decreased bone resorption and increased bone density in patients with osteoporosis are often noted. Blood glucose, erythrocyte production, and the balance of calcium are also affected by androgens. Increased erythrocyte production is apparently due to enhanced production of erythropoietic stimulating factor. Patients with anemia associated with renal disease will have increases in red blood cell volume and hemoglobin after recei